Inozyme Pharma Inc reports results for the quarter ended in September - Earnings Summary

Inozyme Pharma

10/11/2021 14:32

* Inozyme Pharma Inc  INZY.OQ  reported a quarterly adjusted
loss of 60 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 61 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Inozyme Pharma Inc's reported EPS for the quarter was a loss
of 60 cents​.
* The mean earnings estimate of analysts had risen by about 2.4%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Inozyme Pharma Inc shares had fallen by 17.1% this quarter and
lost 53.4% so far this year.
* The company reported a quarterly loss of $14.28 million.
* Wall Street's median 12-month price target for Inozyme Pharma
Inc is $35.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 02:32 p.m.
 ​All figures in US dollars unless otherwise stated